Opportunities and Challenges: Generic Oligonucleotide Drugs
Author/sLuke, Markham
Date:10/08/2024
Meeting Name:FDA and the Center for Research on Complex Generics (CRCG) Workshop on Scientific and Regulatory Considerations for Assessment of Immunogenicity Risk for Generic Peptide and Oligonucleotide Drug Products
State:MD
City:Rockville